Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ALZN | Common Stock | Purchase | $185 | +200 | +0.12% | $0.92 | 167K | Dec 22, 2023 | Direct | |
transaction | ALZN | Common Stock | Purchase | $450 | +500 | +1.96% | $0.90 | 26K | Dec 26, 2023 | By Ault Alpha LP | F1 |
holding | ALZN | Common Stock | 737K | Dec 22, 2023 | By Ault Lending, LLC | F2 | |||||
holding | ALZN | Common Stock | 996K | Dec 22, 2023 | By Ault Life Sciences, Inc. | F3 | |||||
holding | ALZN | Common Stock | 667K | Dec 22, 2023 | By Ault Life Sciences Fund, LLC | F4 |
Id | Content |
---|---|
F1 | Milton C. Ault, III, is the Manager of Ault Alpha GP LLC ("Ault GP") and Ault Capital Management LLC ("AC Management"). Ault GP and AC Management are the general partner and investment manager to Ault Alpha LP, respectively. As such, Mr. Ault is deemed to beneficially own the shares held by Ault Alpha LP. |
F2 | Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Ault Alliance, Inc. ("AAI"). Mr. Ault, the Executive Chairman of AAI, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending. |
F3 | Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc. |
F4 | Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC. |